Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Circ Arrhythm Electrophysiol. 2020 Dec 9;14(1):e008997. doi: 10.1161/CIRCEP.120.008997

Table 2.

AF risk score performance for 5-year incident AF, stroke, and heart failure.

Score
CHA2DS2-VASc C2HEST CHARGE-AF EHR-AF
AF*
 Hazard ratio per SD increase (95% CI) 1.85 (1.84–1.86) 1.88 (1.88–1.89) 2.87 (2.85–2.89) 2.87 (2.86–2.89)
 AIC 4,473,906 4,458,257 4,394,587 4,390,568
 Wald χ2 88,782, p<0.01 113,049, p<0.01 142,925, p<0.01 152,686, p<0.01
 R2 (95% CI) 0.039 (0.038–0.039) 0.039 (0.039–0.040) 0.065 (0.064–0.065) 0.065 (0.064–0.065)
 c-index (95% CI) 0.720 (0.719–0.722) 0.683 (0.682–0.684) 0.806 (0.805–0.807) 0.808 (0.807–0.809)
 Calibration slope (95% CI) 0.398 (0.295–0.400) 0.455 (0.453–0.458) 0.821 (0.816–0.825) 1.002 (0.997–1.007)
Stroke
 Hazard ratio per SD increase (95% CI) 1.76 (1.76–1.77) 1.61 (1.60–1.61) 1.92 (1.91–1.93) 1.84 (1.83–1.85)
 AIC 5,550,757 5,562,546 5,541,413 5,551,439
 Wald χ2 73,374, p<0.01 68,772, p<0.01 77,083, p<0.01 68,101, p<0.01
 R2 (95% CI) 0.022 (0.022–0.022) 0.018 (0.018–0.019) 0.025 (0.025–0.025) 0.022 (0.021–0.022)
 c-index (95% CI) 0.686 (0.684–0.687) 0.670 (0.669–0.672) 0.710 (0.709–0.711) 0.700 (0.699–0.702)
Heart failure§
 Hazard ratio per SD increase (95% CI) 1.91 (1.91–1.92) 1.94 (1.93–1.94) 2.51 (2.50–2.52) 2.58 (2.57–2.59)
 AIC 6,687,160 6,678,595 6,638,481 6,628,574
 Wald χ2 148,962, p<0.01 156,206, p<0.01 161,868, p<0.01 173,488, p<0.01
 R2 (95% CI) 0.037 (0.036–0.037) 0.039 (0.039–0.040) 0.050 (0.050–0.051) 0.053 (0.053–0.054)
 c-index (95% CI) 0.730 (0.729–0.732) 0.733 (0.732–0.734) 0.770 (0.769–0.771) 0.775 (0.774–0.776)
*

N events=153,151, N total=4,508,180, median follow-up, years (Q1,Q3): 3.1 (1.1,5.0)

Akaike Information Criterion (AIC), a penalized likelihood metric. Lower values suggest better model fit while accounting for model complexity.

N events=190,049, N total=4,282,764, median follow-up, years (Q1,Q3): 3.1 (1.1,5.0)

§

N events=230,187, N total=4,342,308, median follow-up, years (Q1,Q3): 3.1 (1.1,5.0)